SuperworthAxsome Therapeutics shares outstanding AXSM
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 51.8M
- On a year earlier
- +4.8%
- more shares
Axsome Therapeutics had 51.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 4.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 50.6M | +4% |
| FY2024 | 48.5M | +3% |
| FY2023 | 47.3M | +9% |
| FY2022 | 43.4M | +15% |
| FY2021 | 37.8M | +1% |
| FY2020 | 37.4M | +7% |
| FY2019 | 34.8M | +16% |
| FY2018 | 29.9M | +23% |
| FY2017 | 24.2M | +26% |
| FY2016 | 19.2M | +33% |
| FY2015 | 14.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 51.8M | +5% | |
| Q1 FY26 | 51.2M | +5% | |
| Q4 FY25 | 50.6M | +4% | |
| Q3 FY25 | 50M | +4% | |
| Q2 FY25 | 49.4M | +4% | |
| Q1 FY25 | 48.9M | +3% | |
| Q4 FY24 | 48.5M | +3% | |
| Q3 FY24 | 48.1M | +2% | |
| Q2 FY24 | 47.6M | +9% | |
| Q1 FY24 | 47.4M | +9% | |
| Q4 FY23 | 47.3M | +9% | |
| Q3 FY23 | 47.1M | +13% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Axsome Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.